Chemomab Therapeutics Ltd DRC
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -33 | |||
EBITDA | -2,066 | -3,487 | -3,196 | -3,710 |
EBIT | -2,099 | -3,500 | -3,213 | -3,726 |
Net Income | -2,057 | -3,323 | -2,963 | -3,483 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cash | 5,448 | 8,338 | 6,071 | 6,601 |
Basic Shares | 1,158 | 22,807 | 18,856 | 17,532 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -53 | -66 | -57 | -34 |
EBITDA | -13,957 | -25,392 | -28,475 | -12,333 |
EBIT | -14,011 | -25,459 | -28,532 | -12,367 |
Net Income | -13,945 | -24,221 | -27,646 | -12,478 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,386 | -23,614 | -20,438 | -12,613 |
Cash | 6,071 | 9,292 | 13,519 | 14,686 |
Basic Shares | 17,952 | 11,749 | 11,379 | 10,373 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.01 |
2025-03-31 | -$0.007 |
2024-12-31 | -$0.008 |
